EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.

EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.

Item
http://www.wikidata.org/entity/Q36166778
Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreenStrong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs.The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literatureIntracellular Acidosis Promotes Mitochondrial Apoptosis Pathway: Role of EMMPRIN Down-regulation via Specific Single-chain Fv IntrabodyPrognostic role of extracellular matrix metalloproteinase inducer/CD147 in gastrointestinal cancer: a meta-analysis of related studies.Expression and clinical significance of Wee1 in colorectal cancer.S100A4 and its role in metastasis – simulations of knockout and amplification of epithelial growth factor receptor and matrix metalloproteinases.CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis.EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.Vascular Invasion and Stromal S100A4 Expression at the Invasive Front of Colorectal Cancer are Novel Determinants and Tumor Prognostic Markers.The clinicopathological significance and prognostic value of EMMPRIN overexpression in cancers: evidence from 39 cohort studies.ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study.Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.
P2860

EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.

Item
http://www.wikidata.org/entity/Q36166778
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
@ast
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
@en
type
label
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
@ast
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
@en
prefLabel
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
@ast
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932